Similarly, the bevacizumab vial form exhibited higher IOP values than the ranibizumab PFS form; however, this discrepancy did not reach statistical significance ( p = 0.276).
← all excerpts
Effect of Estimated Individual Vitreous Volume on Intraocular Pressure Spikes after Intravitreal Anti-Vascular Endothelial Growth Factors Injection.
1
0.2760
0.2760